Skip to main content

Advertisement

Table 1 Patient characteristics

From: Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma

Variables n = 129  
Age 54.0 ± 12.6  
FIGO stage, n, (%)
 I 17 (13.2%)
 II 76 (58.9%)
 III 17 (13.2%)
 IV 19 (14.7%)
Tumor size (cm) 4.5 ± 1.5  
SCC antigen (ng/mL) 14.8 ± 28.1  
Lymph node metastasis status, n, (%)
 Pelvic lymph node 61 (47.3%)
 Para-aortic lymph node 18 (14.0%)
PET parameter
 pSUVmax 13.0 ± 6.9  
 Nodal SUVmax 2.3 ± 5.0  
HPV infection, n (%) 111 (86.0%)
Median follow-up (months) 60  
  1. FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, PET positron emitting tomography, SUVmax maximum standardized uptake, pSUVmax SUVmax of primary tumor, nodal SUVmax SUVmax of the lymph node with the highest FDG uptake, HPV human papilloma virus